ACAD(Acadia Pharmaceuticals Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-30 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 3,321 | $20.88 |
| 2026-08-06 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 9,292 | $29.34 |
| 2026-08-06 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 5,000 | $29.00 |
| 2026-08-05 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 5,849 | $29.00 |
| 2026-07-30 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 公开市场卖出 | 50 | $26.17 |
| 2026-07-30 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 公开市场卖出 | 16,508 | $26.13 |
| 2026-06-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 11,421 | $26.08 |
| 2026-05-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 5,401 | $21.18 |
| 2026-05-04 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 3,506 | $21.79 |
| 2026-05-04 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 1,332 | $21.79 |
| 2026-04-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 2,709 | $22.20 |
| 2026-04-07 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 1,030 | $22.20 |
| 2026-03-26 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 37 | $21.72 |
| 2026-03-26 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 3,171 | $21.65 |
| 2026-03-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 12 | $21.73 |
| 2026-03-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 1,097 | $21.65 |
| 2026-03-25 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 公开市场卖出 | 4,177 | $21.47 |
| 2026-03-25 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 公开市场卖出 | 3,435 | $21.47 |
| 2026-03-25 | Owen Adams Catherine | Chief Executive Officer | 公开市场卖出 | 11,641 | $21.47 |
| 2026-03-25 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 公开市场卖出 | 833 | $21.47 |